|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
91,540,000 |
Market
Cap: |
34.79(M) |
Last
Volume: |
1,296,467 |
Avg
Vol: |
1,292,882 |
52
Week Range: |
$0.38 - $0.9341 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Curis is a biotechnology company focused on the development of therapeutics for the treatment of cancer. Co.'s clinical stage drug candidates are: Emavusertib, which is being tested in a Phase 1/2 dose escalating clinical trial in patients with non-Hodgkin lymphomas; CI-8993, which is a monoclonal antibody; Fimepinostat, which is a small molecule that potently inhibits the activity of histone deacetylase, and phosphotidyl-inositol 3 kinase; CA-170, for which Co. has announced initial data from a clinical study in patients with mesothelioma in conjunction with the Society of lmmunotherapy of Cancer; and CA-327, which is a small molecule antagonist of PDL1 and TIM3.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-12-03 |
4 |
OE |
$0.80 |
$42,969 |
D/D |
21,875 |
0 |
|
- |
|
Gray Michael |
Chief Financial Officer |
|
2004-12-02 |
4 |
S |
$4.50 |
$81,682 |
D/D |
(18,107) |
0 |
|
- |
|
Gray Michael |
Chief Financial Officer |
|
2004-12-02 |
4 |
OE |
$1.50 |
$27,161 |
D/D |
18,107 |
0 |
|
- |
|
Mcnab James R |
Director |
|
2004-12-01 |
4 |
B |
$4.10 |
$119,335 |
I/I |
29,075 |
100,000 |
2.1 |
- |
|
Mcnab James R |
Director |
|
2004-11-30 |
4 |
B |
$4.04 |
$128,804 |
I/I |
31,900 |
0 |
2.1 |
- |
|
Gray Michael |
Chief Financial Officer |
|
2004-09-13 |
4 |
S |
$4.55 |
$51,188 |
D/D |
(11,250) |
0 |
|
- |
|
Gray Michael |
Chief Financial Officer |
|
2004-09-13 |
4 |
OE |
$1.09 |
$12,263 |
D/D |
11,250 |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-09-03 |
4 |
S |
$4.25 |
$26,563 |
D/D |
(6,250) |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-09-03 |
4 |
OE |
$0.80 |
$5,000 |
D/D |
6,250 |
0 |
|
- |
|
Mcnab James R |
Director |
|
2004-08-17 |
4 |
OE |
$2.43 |
$161,656 |
D/D |
65,625 |
849,869 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-21 |
4 |
S |
$4.75 |
$27,419 |
D/D |
(5,761) |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-21 |
4 |
OE |
$2.43 |
$13,999 |
D/D |
5,761 |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-17 |
4 |
S |
$4.75 |
$46,346 |
D/D |
(9,739) |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-17 |
4 |
OE |
$2.43 |
$23,666 |
D/D |
9,739 |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-16 |
4 |
S |
$4.75 |
$74,950 |
D/D |
(15,750) |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-16 |
4 |
OE |
$2.43 |
$38,273 |
D/D |
15,750 |
0 |
|
- |
|
Noel Mark |
VP, Tech Mgt and Bus Dev |
|
2004-06-14 |
5 |
A |
$3.73 |
$2,850 |
D/D |
764 |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-08 |
4 |
S |
$4.30 |
$112,156 |
D/D |
(25,300) |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-06-08 |
4 |
OE |
$0.80 |
$20,502 |
D/D |
25,300 |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-06-01 |
4 |
S |
$4.50 |
$45,355 |
D/D |
(10,000) |
9,814 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-06-01 |
4 |
OE |
$1.50 |
$15,000 |
D/D |
10,000 |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-05-28 |
4 |
S |
$4.50 |
$20,700 |
D/D |
(4,600) |
9,814 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-05-28 |
4 |
OE |
$1.50 |
$6,900 |
D/D |
4,600 |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-05-03 |
4 |
S |
$4.55 |
$13,213 |
D/D |
(2,900) |
9,814 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-05-03 |
4 |
OE |
$1.50 |
$4,350 |
D/D |
2,900 |
0 |
|
- |
|
303 Records found
|
|
Page 9 of 13 |
|
|